The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (4) , 787-792
- https://doi.org/10.1016/0006-2952(90)90160-m
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- The effect of verapamil on the pharmacokinetics of adriamycinCancer Chemotherapy and Pharmacology, 1986
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell linesBiochemical Pharmacology, 1986
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heartBritish Journal of Pharmacology, 1985
- Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.British Journal of Clinical Pharmacology, 1984
- Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cellsBritish Journal of Cancer, 1984
- Reversal of Adriamycin Resistance by Verapamil in Human Ovarian CancerScience, 1984